Gyeonggi-do, South Korea

Ran Namgung

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ran Namgung. Retrieved from https://idiyas.com/inventor/ran-namgung-vutpgqi5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ran Namgung

Introduction

Ran Namgung is an accomplished inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of gene delivery systems. His work focuses on the development of innovative gene carriers that enhance the efficiency of genetic material transfer.

Latest Patents

Ran Namgung holds a patent for a "Conjugate of arm-type polyethyleneglycol with linear polyethyleneimine as gene carrier and synthesis thereof." This patent discloses a novel gene carrier in which polyethyleneglycol is conjugated with polyethyleneimine. The gene carrier is particularly useful for transferring DNA, siRNA, and negatively charged peptides, showcasing its potential in therapeutic applications.

Career Highlights

Ran Namgung is affiliated with the Postech Academy-Industry Foundation, where he continues to advance his research in gene delivery technologies. His work has garnered attention for its innovative approach to solving challenges in genetic engineering.

Collaborations

Ran Namgung collaborates with various professionals in his field, including his coworker, Won Jong Kim, who is also a notable figure in the research community.

Conclusion

Ran Namgung's contributions to the field of gene carriers highlight the importance of innovation in biotechnology. His work not only advances scientific understanding but also paves the way for future developments in gene therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…